Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis

被引:50
作者
Blavier, L
Lazaryev, A
Dorey, F
Shackleford, GM
DeClerck, YA
机构
[1] Childrens Hosp Los Angeles, Dept Pediat, Los Angeles, CA USA
[2] Childrens Hosp Los Angeles, Div Hematol Oncol, Los Angeles, CA 90027 USA
[3] USC Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA USA
[4] USC Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA USA
[5] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA
关键词
D O I
10.1158/0008-5472.CAN-05-2919
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Wnt signaling transduction pathway plays a critical role in the pathogenesis of several murine and human epithelial cancers. Here, we have used mouse mammary tumor virus (MMTV)-Wnt1 transgenic mice, which develop spontaneous mammary adenocarcinoma, to examine whether matrix metalloproteinases (MMPs)-a family of extracellular proteases implicated in multiple steps of cancer progression-contributed to Wnt1-induced tumorigenesis. An analysis of the expression of several MMPs by RT-PCR and in situ hybridization revealed an increase in the expression of MMP-2, MMP-3, MMP-9, MMP-13, and MT1-MMP (MMP-14) in hyperplastic glands and in mammary tumors of MMTV-Wnt1 trans,genic mice. Interestingly, whereas MMP-2, MMP-3, and MMP-9 were exclusively expressed by stromal cells in mammary tumors, MMP-13 and MT1-MMP were expressed by transformed epithelial cells in addition to the tumor stroma. To determine whether these MMPs contributed to tumorigenesis, MMTV-Wnt1 mice were crossed with transgenic mice overexpressing tissue inhibitor of metalloproteinase-2-a natural NIMP inhibitor-in the mammary gland. In the double MMTV-Wnt1 /tissue inhibitor of metalloproteinases-2 transgenic mice, we observed an increase in tumor latency and a 26.3% reduction in tumor formation. Furthermore, these tumors grew at a slower rate, exhibited an 18% decrease in proliferative rate, and a 12.2% increase in apoptotic rate of the tumor cells in association with a deficit in angiogenesis when compared with tumors from TIMITAI-Wntl mice. Thus, for the first time, the data provides evidence for the active role of MMPs in Wnt1-induced mammary tumorigenesis.
引用
收藏
页码:2691 / 2699
页数:9
相关论文
共 54 条
[1]  
Almholt K, 2003, RECENT RESULTS CANC, V162, P31
[2]   Functional interaction of beta-catenin with the transcription factor LEF-1 [J].
Behrens, J ;
vonKries, JP ;
Kuhl, M ;
Bruhn, L ;
Wedlich, D ;
Grosschedl, R ;
Birchmeier, W .
NATURE, 1996, 382 (6592) :638-642
[3]   Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis [J].
Bergers, G ;
Brekken, R ;
McMahon, G ;
Vu, TH ;
Itoh, T ;
Tamaki, K ;
Tanzawa, K ;
Thorpe, P ;
Itohara, S ;
Werb, Z ;
Hanahan, D .
NATURE CELL BIOLOGY, 2000, 2 (10) :737-744
[4]   Tissue inhibitors of matrix metalloproteinases in cancer [J].
Blavier, L ;
Henriet, P ;
Imren, S ;
DeClerck, YA .
INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS, 1999, 878 :108-119
[5]   Tissue inhibitor of metalloproteinases-2 is expressed in the interstitial matrix in adult mouse organs and during embryonic development [J].
Blavier, L ;
DeClerck, YA .
MOLECULAR BIOLOGY OF THE CELL, 1997, 8 (08) :1513-1527
[6]  
Bocchinfuso WP, 1999, CANCER RES, V59, P1869
[7]   CDNA CLONING AND EXPRESSION OF A METALLOPROTEINASE INHIBITOR RELATED TO TISSUE INHIBITOR OF METALLOPROTEINASES [J].
BOONE, TC ;
JOHNSON, MJ ;
DECLERCK, YA ;
LANGLEY, KE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (07) :2800-2804
[8]   Tissue inhibitors of metalloproteinases: evolution, structure and function [J].
Brew, K ;
Dinakarpandian, D ;
Nagase, H .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2000, 1477 (1-2) :267-283
[9]   Wnt signaling: a common theme in animal development [J].
Cadigan, KM ;
Nusse, R .
GENES & DEVELOPMENT, 1997, 11 (24) :3286-3305
[10]   Stromal matrix metalloproteinase-9 regulates the vascular architecture in neuroblastoma by promoting pericyte recruitment [J].
Chantrain, CF ;
Shimada, H ;
Jodele, S ;
Groshen, S ;
Ye, W ;
Shalinsky, DR ;
Werb, Z ;
Coussens, LM ;
DeClerck, YA .
CANCER RESEARCH, 2004, 64 (05) :1675-1686